Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge (EPICOR)

AstraZeneca

Status: Completed

Conditions: Coronary Artery Disease; Unstable Angina; Acute Coronary Syndrome; ACS; Myocardial Infarction

Study type: Observational

Funder types: Industry

Identifiers

NCT01171404

NIS-CEU-DUM-2009/1

Details and patient eligibility

About

The aim of this international study is to describe the short- and long-term (i.e. up to 2 years following the index event) antithrombotic management patterns (AMPs) in patients hospitalized for acute coronary syndromes (ST segment elevation myocardial infarction (STEMI), Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS)), and to document the impact of AMPs in clinical outcomes, economic variables and quality of life in a 'real-life' setting and to compare these between sites, countries and regions.

Enrollment: 10,568 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of myocardial infarction or unstable angina
• Hospitalized for the first time within 24 hours of onset of symptoms

Exclusion criteria

• Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances)
• Current participation in a clinical trial.

Trial design

10,568 participants in 1 patient group

1

Description:

Patients, older than 18, hospitalized within 24 hours of onset of symptoms and diagnosed with UA, STEMI or NSTEMI